6-KThe Wire
GENMAB A/S files 6-K
Filed Apr 17, 2026 · 2mo ago · Accession 0001434265-26-000063
Plain English
Genmab A/S announced on April 17, 2026, that it has entered into a definitive agreement to acquire all outstanding shares of Cytomx Therapeutics, Inc. for $300 million.
Filing details
- Company
- GENMAB A/S
- Ticker
- GMAB
- CIK
- 1434265
- Form type
- 6-K
- Filing date
- Apr 17, 2026
- Report date
- Apr 17, 2026
- Document
- gmab_20260417x6k.htm
- Size
- 102 KB